SEC Form 424B3 filed by SBC Medical Group Holdings Incorporated
$SBC
Medical/Nursing Services
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)
3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)
4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)
SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the three months ended March 31, 2025. First Quarter 2025 Highlights Total revenues were $47 million, representing a 14% year-over-year decrease. Income from operations was $24 million, representing a 1% year-over-year decrease. Net Income attributable to SBC Medical Group was $22 million, representing a 15% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, "the Company") today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program Maximum aggregate amount: US $5 millionImplementation period: May 20, 2025 – May 20, 2026Funding source: Surplus cash and future free cash flow The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic‑medical market, and its position as an industry leader. Based on this view, it has decided to purchase shares on the ope
SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for -the three months ended December 31, 2024 and full year 2024. Fourth Quarter 2024 Highlights Total revenues were $44 million, representing a 29% year-over-year decrease. Gross profit was $34 million, representing a 22% year-over-year decrease. Income from operations was $5 million, representing an 80% year-over-year decrease. EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss to income from operations was $
DEF 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)
424B3 - SBC Medical Group Holdings Inc (0001930313) (Filer)
PRE 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global franchise and provider of services for aesthetic clinics, today announced its upcoming investor event attendance. SBC Medical managements will be participating in a webcast company presentation and will also attend 1-x-1 investor meetings at these upcoming events: 1. Lytham Partners Spring 2025 Virtual Investor Conference Company WebcastThursday, May 29, 2025, at 2:00-2:30 PM(ET) The webcast can be accessed at https://app.webinar.net/LOrnzdv9Dj1Post-Event Access: Same as above 1x1 MeetingsTo arrange a meeting at https://lythampartners.com/
SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the three months ended March 31, 2025. First Quarter 2025 Highlights Total revenues were $47 million, representing a 14% year-over-year decrease. Income from operations was $24 million, representing a 1% year-over-year decrease. Net Income attributable to SBC Medical Group was $22 million, representing a 15% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, "the Company") today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program Maximum aggregate amount: US $5 millionImplementation period: May 20, 2025 – May 20, 2026Funding source: Surplus cash and future free cash flow The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic‑medical market, and its position as an industry leader. Based on this view, it has decided to purchase shares on the ope